Your session is about to expire
← Back to Search
Light Therapy for Oral Mucositis
Study Summary
This trial will use light therapy to try to reduce the occurrence and severity of mucositis in patients treated with radiotherapy for head and neck cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a skin condition that worsens with sunlight exposure.My mouth is healthy without sores or infections.My oral cancer surgery removed all visible cancer, and there's no large lymph node cancer in the treatment area.I have had radiation therapy to my head or neck area.I am 18 years old or older.I am fully active or can carry out light work.I am scheduled for radiation treatment of 50 Gy or more.I still have visible cancer after surgery in the area to be treated.I am currently being treated with Cetuximab.I have not had chemotherapy in the last 3 months.
- Group 1: Photobiomodulation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this trial still accepting participants?
"Indeed, the clinicaltrials.gov web page clarifies that this medical experiment is still recruiting patients. It was initially posted on June 1st 2021 and has been updated as recently as September 9th 2021. 25 subjects are needed from one medical site to complete the trial."
To what extent has enrollment progressed in this trial?
"Indeed, according to the clinicaltrials.gov website, this research trial is currently enrolling participants. The protocol was initially published on June 1st 2021 and has recently undergone a modification as of September 9th 2021. 25 patients must be gathered from one medical facility for participation in the study."
Share this study with friends
Copy Link
Messenger